Viking Therapeutics, Inc. (VKTX) closed at $28.19 in the latest trading session, marking a +1.7% move from the prior day.

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Get the cash flow statement for Viking Therapeutics, Inc. (VKTX). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue.

Review Viking Therapeutics Inc (VKTX:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target of $102.00. The company’s shares ...

Read about Viking Therapeutics Inc (VKTX:XNAS) stock and today's latest news and financial updates.

Nasdaq Listed Alerts Market: After-Hours Viking Therapeutics, Inc. Common Stock (VKTX) Bid: $27.09 X 3 Ask: $27.33 X 150 Volume: 4,163,488 ...